BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 6.96% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 6.82% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 5.12% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 4.69% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.14% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.90% |
| 207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 3.61% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.45% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 3.40% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 3.34% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.27% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 2.75% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.68% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.62% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 2.62% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.30% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.29% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.09% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 1.92% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.88% |